Skip to content
رانیرستات

Structure via PubChem · Public domain (PubChem)

EntityQ7293074· pop 7· linked from 141 articles

رانیرستات

Sign in to save

Also known as Ranirestat

Ranirestat (also known as AS-3201) is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy by Dainippon Sumitomo Pharma and PharmaKyorin. It has been granted orphan drug status. The drug is to be used orally.

Chemical data

Formula
C17H11BrFN3O4
Molecular weight
420.2 g/mol
IUPAC name
(3R)-2'-[(4-bromo-2-fluorophenyl)methyl]spiro[pyrrolidine-3,4'-pyrrolo[1,2-a]pyrazine]-1',2,3',5-tetrone
SMILES
C1C(=O)NC(=O)[C@@]12C(=O)N(C(=O)C3=CC=CN23)CC4=C(C=C(C=C4)Br)F
InChIKey
QCVNMNYRNIMDKV-QGZVFWFLSA-N
XLogP
1.3
Polar surface area
88.5 Ų
H-bond donors
1
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 3
Molecule type
Small molecule
Indications
polyneuropathy, diabetic neuropathy

via ChEMBL · EBI

Wikidata facts

Mass
418.992
Show 5 more facts
canonical SMILES
C1C(=O)NC(=O)C12C(=O)N(C(=O)C3=CC=CN23)CC4=C(C=C(C=C4)Br)F
chemical formula
C₁₇H₁₁BrFN₃O₄
isomeric SMILES
C1C(=O)NC(=O)[C@@]12C(=O)N(C(=O)C3=CC=CN23)CC4=C(C=C(C=C4)Br)F
subject has role
enzyme inhibitor
Commons category
Ranirestat
Sources (2)

via Wikidata · CC0

Available in 6 languages

via Wikidata sitelinks · CC0